Six innovation strategies for Life Science organizations in 2023
IBM Services
FEBRUARY 16, 2023
The macro-environment favors steady long-term focus and growth The Inflation Reduction Act of 2022 puts pressure on companies to reduce drug and device prices in the USA, causing pharma to leverage technology to drive cost efficiencies and maintain margins. Manufacturing costs and costs of clinical trials will continue to rise.
40 
Let's personalize your content